For access to the publication, visit: Freeman et al. Real-World Evidence of Growth Improvement in Children 1 to 5 Years of ...
Cred Alcresta announced the availability of Relizorb (immobilized lipase), a novel digestive enzyme cartridge that hydrolyzes fats in enteral tube feeding formula to mimic normal pancreatic function.
Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel enzyme-based products, announced that Inova Fairfax Medical Campus (Inova) has enrolled ...
Redding, California, Feb. 08, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled ‘Enteral Feeding Devices Market by Product (Feeding Pumps, Feeding Tubes, Enteral Syringes, ...
Research and Markets has announced the addition of the "Enteral Feeding Devices Market by Product (Feeding Pump, Feeding Tube, Giving Set, Enteral Syringes), Stage (Adult, Pediatrics), Application ...
Baltimore-based medical device startup CoapTech reached a key milestone in April: It can now market its product that allows the placement of a feeding tube without the need for an operating room.
The rise in the patient population with malnutrition, the high demand for tube feeding among cancer patients, the increased demand for low-profile enterostomy feeding tubes, and high growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results